Acrivon Therapeutics, Inc. Common StockACRVNASDAQ
Loading
Total Assets Over TimeContracting
Percentile Rank40
3Y CAGR-10.5%
5Y CAGR+126.3%
Year-over-Year Change
Total value of everything the company owns
3Y CAGR
-10.5%/yr
Annual compound
5Y CAGR
+126.3%/yr
Recent deceleration
Percentile
P40
Within normal range
vs 5Y Ago
59.4x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $129.72M | -34.0% |
| 2024 | $196.59M | +42.2% |
| 2023 | $138.26M | -23.7% |
| 2022 | $181.23M | +70.0% |
| 2021 | $106.59M | +4778.1% |
| 2020 | $2.19M | - |